$449 Million is the total value of Boussard & Gavaudan Investment Management LLP's 23 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% . Boussard & Gavaudan Investment Management LLP is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IIVI | Exit | II VI INC | $0 | – | -11,188 | -100.0% | -0.05% | – |
| LBTYA | Exit | LIBERTY GLOBAL PLC | $0 | – | -34,484 | -100.0% | -0.11% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -11,591 | -100.0% | -0.14% | – |
| L100PS | Exit | ARCONIC INC | $0 | – | -46,483 | -100.0% | -0.16% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -23,173 | -100.0% | -0.23% | – |
| MSGN | Exit | MSG NETWORK INCcl a | $0 | – | -287,028 | -100.0% | -0.88% | – |
| GLIBA | Exit | GCI LIBERT INC | $0 | – | -129,233 | -100.0% | -1.07% | – |
| AXTA | Exit | AXALTA COATING SYS LTD | $0 | – | -298,024 | -100.0% | -1.21% | – |
| LBTYK | Exit | LIBERTY GLOBAL PLC | $0 | – | -329,822 | -100.0% | -1.26% | – |
| DEACU | Exit | DIAMOND EAGLE ACQUISITION COunit | $0 | – | -1,003,270 | -100.0% | -1.36% | – |
| WBC | Exit | WABCO HLDGS | $0 | – | -110,386 | -100.0% | -1.98% | – |
| TIF | Exit | TIFFANY & CO NEW | $0 | – | -179,715 | -100.0% | -2.24% | – |
| CSTM | Exit | CONSTELLIUM SEcl a | $0 | – | -3,326,775 | -100.0% | -5.67% | – |
| AABA | Exit | ALTABA INC | $0 | – | -3,894,294 | -100.0% | -10.12% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -2,558,564 | -100.0% | -33.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALIBABA GROUP HLDG LTD | 20 | Q1 2022 | 93.8% |
| CRITEO S A | 16 | Q2 2018 | 22.5% |
| LIBERTY BROADBAND CORP | 15 | Q3 2023 | 5.3% |
| TIM PARTICIPACOES S A | 14 | Q2 2018 | 46.5% |
| TIFFANY & CO NEW | 14 | Q3 2020 | 11.0% |
| AMBAC FINL GROUP INC | 14 | Q3 2023 | 2.4% |
| CONSTELLIUM SE | 14 | Q3 2019 | 5.7% |
| CONSTELLIUM SE | 13 | Q4 2022 | 12.4% |
| ASHLAND INC | 12 | Q2 2023 | 5.9% |
| MEAD JOHNSON NUTRITION CO | 11 | Q1 2017 | 36.9% |
View Boussard & Gavaudan Investment Management LLP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-12 |
| 13F-HR/A | 2022-02-15 |
| 13F-HR | 2022-02-10 |
View Boussard & Gavaudan Investment Management LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.